Cleared Traditional

K180232 - DAEHAN Disposable CUP Electrodes

K180232 is the FDA 510(k) clearance for DAEHAN Disposable CUP Electrodes by Daehan Medical Systems Co., Ltd.. It is a Class 2 Neurology device (product code GXY) cleared through the Traditional 510(k) pathway after a 429-day FDA review.

K180232 · Daehan Medical Systems Co., Ltd. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2019
Decision
429d
Days
Class 2
Risk

K180232 is an FDA 510(k) clearance for the DAEHAN Disposable CUP Electrodes. Classified as Electrode, Cutaneous (product code GXY), Class II - Special Controls.

Submitted by Daehan Medical Systems Co., Ltd. (Siheung-City, KR). The FDA issued a Cleared decision on April 3, 2019 after a review of 429 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1320 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Neurology submissions.

View all Daehan Medical Systems Co., Ltd. devices

Submission Details

510(k) Number K180232 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 29, 2018
Decision Date April 03, 2019
Days to Decision 429 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
281d slower than avg
Panel avg: 148d · This submission: 429d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code GXY Electrode, Cutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1320
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GXY Electrode, Cutaneous

All 141
Devices cleared under the same product code (GXY) and FDA review panel - the closest regulatory comparables to K180232.
ELECTRODES PAD
K190700 · Shenzhen Bestpad Technology Development Co., Ltd. · Jun 2019
COMPLETE CONTROL System Gen2
K191083 · Coapt, LLC · May 2019
Dome Electrode
K190416 · Coapt, LLC · Apr 2019
SM Electrodes
K183154 · Hong Qiangxing (Shenzhen) Electronics Limited · Mar 2019
DL Self-adhesive Electrode
K182111 · Shaoxing DL Healthcare Co., Ltd. · Jan 2019
Espire Elbow Pro, Espire Elbow Hybrid
K182757 · College Park Industries, Inc. · Nov 2018